Chargement en cours...
High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
Immunotherapies have dramatically improved survival outcome for patients with melanoma. MUC16 encodes cancer antigen 125 (CA125), which is frequently mutated in melanoma. In this study, we correlated the MUC16 mutational status with the following: tumor mutation burden (TML), multiple immune-related...
Enregistré dans:
| Publié dans: | Aging (Albany NY) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346065/ https://ncbi.nlm.nih.gov/pubmed/32491995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103296 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|